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Abstract 
The search for longevity genes has greatly developed in recent years basing on the idea that a 
consistent part of longevity is determined by genetics. The ultimate goal of this research is to identify 
possible genetic determinants of human aging and longevity, but studies on humans are limited by a 
series of critical restrictions. For this reason, most of the studies in this field have been, and still are, 
performed on animal models, basing on the assumption that fundamental biological mechanisms are 
highly conserved throughout evolution and that, accordingly, extrapolation from model systems to humans 
is quite reasonable. Indeed, many comparative data obtained on single genes or gene families fit with this 
assumption. However, it is also clear that, despite such a basic conservative scenario, major changes also 
occurred in evolution, particularly regarding biological regulatory processes and integration between and 
among pathways. This consideration raises the fundamental question of the transferability of the results 
obtained from model systems to humans. In this review, we discuss the differences between animal 
models and men regarding the genetics of aging and longevity, and the possible reasons that can 
explain such discrepancies, with a particular emphasis on the phenomena of conservation and 
evolvability of biological systems. Finally we will suggest a possible strategy to identify putative 
longevity genes basing on their position inside conserved metabolic structures. 
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Introduction 
 
In biological studies, the reductionist approach 
has been very successful, and the use of simple 
experimental models allowed the researcher to 
obtain an exceptional number of results. The most 
popular example of this approach is represented by 
the bacteriovorous nematode Caenorhabditis 
elegans, a small worm composed of 959 cells in the 
adult hermaphrodite form. A defined subset of 131 
cells undergoing programmed cell death has 
allowed to the identification of specific apoptosis-
related genes, the so called CED genes (Hengartner 
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and Horvitz, 1994). Cloning of these C. elegans 
genes has revealed that nematodes and mammals 
share a common pathway for programmed cell 
death. The same reductionist approach has led to 
the identification of longevity genes in C. elegans 
since 1988 (Friedman and Johnson, 1988). In 1992, 
Johnson and Lithgow wrote: “If we are fortunate and 
aging processes exhibit evolutionary conservation, 
many exciting possibilities await”. At least in some 
cases, human homologs of invertebrate longevity 
genes have been found (in particular genes 
belonging to the IGF-1 signalling pathway, see 
Barbieri et al., 2003). Such similarities are striking 
and suggest that the insulin/IGF-I regulatory system 
arose early in evolution and that the fundamental 
mechanisms that control aging and longevity may 
be evolutionarily conserved from invertebrates 
(and even yeast) to mammals, not excluding humans. 
  112Table 1 Comparison between animals and humans as experimental models for genetic studies on aging and 
longevity. *shorter life span and genetic inbreeding can be both advantageous and disadvantageous. For 
example, it is questioned whether the effect of the accumulation of mtDNA mutations on aging can be seen in 
mice that live only two years at maximum (Santoro et al., 2006). Genetic inbreeding is generally advantageous, 
but it has hampered to discover the effects of mtDNA haplogroups on longevity, that can only be seen in outbred 
populations as humans are (De Benedictis et al., 1999). 
 
  Animal models  Humans 
Advantages  z  shorter life span* 
z genetically  inbred* 
z  possibility to use very high number 
of subjects 
z controlled  environment 
z  simple organisms (especially if 
invertebrates) 
z  subjects can be easily genetically 
manipulated 
 
z  Many genes involved in 
longevity has been 
discovered only in 
human studies 
Disadvantages  z  shorter life span* 
z genetically  inbred* 
z  genetic and epigenetic differences 
with respect to humans 
z  different level of complexity with 
respect to humans 
z  long life span 
z complex  organisms 
z  no possibility of genetic 
manipulation 
z large  population-
specific genetic 
differences 
z  profound influence of 
the environmental 
background 
z  presence of cultural 
factors  
 
 
 
 
Other than the relative simplicity of the organism to 
be studied, C. elegans has many other evident 
advantages over different experimental models: for 
example the short life-span, that allows the 
execution of experiments in short times 
(experiments that otherwise will be intolerably 
longer in animal species with a life span of many 
years, like primates). Another advantage is the 
great number of animals that can be studied with a 
relatively small effort, and most importantly, the 
possibility to easily manipulate the genome of such 
animals, in order to obtain data on the role of 
particular genes in the aging process or in life span 
control. These and other pros and cons of 
invertebrates experimental models are listed in 
Table 1. The main problem with these experimental 
models is that, for a series of reasons, we were not 
so fortunate as hoped by Johnson and Lithgow. 
Indeed, many data obtained on animal models 
were not confirmed on humans or, on the contrary, 
some contributions to the genetics of longevity 
were discovered in humans and not always have 
been replicated in animals (Franceschi et al., 
2007). In this review we will briefly summarise 
some paradigmatic cases in which results found in 
animals have not been reproduced in men and vice 
versa,  and we will discuss the possible reasons 
that can explain these differences, with a particular 
emphasis on two striking features of the conserved 
biological structures, i.e. conservation and 
evolvability. 
 
Genetics of aging and longevity 1: the case of 
p66
Shc gene 
 
Possible reason for the discrepancies between 
data obtained from animal models and humans can 
be the profound differences in the environment 
where experimental animals and humans live in. 
Only recently it has been considered by researchers 
that the animals used for experiments live all their 
entire life in safe and pathogen-free environment. 
They do not have to cope with predators or 
pathogens, they do not suffer famine, they even do 
not have to struggle for food, nor to compete for 
reproduction. This setting assures basic requirement 
of scientific research, i.e. the possibility to replicate 
the results in different laboratories, but of course it is 
a strongly unnatural situation that may lead to 
confounding results, especially when studying the 
genetics of aging and longevity. An example of such 
situation is given by the discovery that the ablation 
of p66
Shc gene leads to an enhancement of 
longevity in mice (Migliaccio et al., 1999). A fraction 
of p66
Shc has a mitochondrial localization where it 
can oxidise cytochrome c and give rise to the 
production of radical oxygen species (ROS) (Giorgio 
et al., 2005), and the localization to mitochondria 
seems to be regulated by PKC-β and Pin-1 (Pinton 
et al., 2006). Thus, it seems that p66
Shc gene 
impinges upon aging and longevity by regulating the 
resistance to oxidative stress-mediated apoptosis 
(Trinei  et al., 2002). Then, if p66
Shc is a bona fide 
 
  113pro-aging gene, one should expect that long living 
animals do express this gene at low levels. To date, 
this hypothesis has not yet been tested. However, 
we studied p66
Shc expression in humans, and, 
unexpectedly, we found that centenarians have 
higher levels of p66
Shc with respect to young people 
(Pandolfi  et al., 2005). These findings lead to the 
conclusion that the effect on longevity of p66
Shc is 
either species-specific, or highly dependent on the 
environmental conditions. Supposing that such 
effects are not species-specific, it has to be 
considered that all animal species including humans 
are evolved and still live in an environment that is 
profoundly different from that of a laboratory (for 
example it is very dirty from an immunological point 
of view), thus it can not be excluded that p66
Shc has 
important effects for the fitness of the organism in 
the wild that are not necessary in a cage. To say, it 
is possible that p66
Shc-/- animals can have some 
disadvantages in survival with respect to wild type 
animals, and that such effects only become evident 
in the environment where genetic selection 
occurred. Finally, it must be also considered that the 
ablation of p66
Shc gene can lead to an altered stress 
response that may be the real responsible for the 
increased life span observed in p66
Shc-/- animals. 
 
Genetics of aging and longevity 2: the case of 
mitochondrial DNA 
 
The contribution to longevity of the inherited 
variants of mitochondrial DNA (mtDNA) has been 
neglected until studies performed on humans 
addressed the question. In particular, some 
haplogroups of the mtDNA have been found to be 
more represented among centenarians and long-
living subjects with respect to younger people 
(Tanaka  et al., 1998; De Benedictis et al., 1999). 
This discovery would have never come from inbred 
animals which share the same mtDNA molecule 
(mtDNA does not recombine and it is inherited only 
from the mother). The involvement of mtDNA 
inherited variants in longevity has not yet been 
confirmed in animals, but other very elegant 
experiments in mice have indicated that such 
variants can modulate functions that are likely 
important for survival, such as memory and learning 
(Roubertoux et al., 2003). A possible positive role in 
longevity for specific somatic mutations of the 
mtDNA has also been postulated basing on studies 
on humans (Zhang et al., 2003; Niemi et al., 2005; 
Rose et al., 2007). The C150T mutation in the D-
loop of the mtDNA molecule in particular has been 
found to be more represented in long-living people 
with respect to younger counterparts. Such a 
mutation seems to cause an alternative origin of 
replication of the mtDNA strands and would be thus 
advantageous for mtDNA pool maintenance (Zhang 
et al., 2003). More recently it has been reported that 
the tendency to accumulate somatic mutations at 
the mtDNA seems to be genetically controlled, since 
centenarians and their offspring and nephews share 
the same levels of mtDNA heteroplasmy at the level 
of D-loop, which differ from that of unrelated people 
(Rose  et al., 2007). These figures indicate that, 
despite their usefulness, animal models are unable 
to identify all the genetic determinants of human 
longevity, because of intrinsic limitations of the 
model, or for specific differences between animals 
and humans. The opposite situation is also possible, 
that is, results obtained in animal models that can 
not be reproduced in humans. For example, recent 
findings indicate that mtDNA point mutations can 
accumulate in organs and tissues without affecting 
aging in mice (Vermulst et al., 2007), but still the 
levels of mtDNA mutations found in such a model 
(Polg
mut/+ mice) are much higher than that found in 
aged human colonic crypts (Taylor et al., 2003), thus 
suggesting that the functional impact of mtDNA 
mutations is likely different in mice and humans 
(Khrapko and Vijg, 2007).  
 
Genetics of aging and longevity 3: population 
heterogeneity, heterozigosity and homozygosity 
 
A peculiar contribution to the study of the 
genetics of aging and longevity has come from 
observations on the levels of heterozygosity and 
homozygosity of genetic loci of interest. It is 
generally accepted that natural selection awards 
heterozygosity as a way to attain high levels of 
fitness during the reproductive period. Nevertheless, 
it was not known whether the levels of 
heterozygosity were also fitting with longevity. By 
studying people of different ages including 
centenarians we observed that, contrary to what it 
was expected, the level of homozygosity of a locus 
in chromosome 1p35 was increased in centenarians 
with respect to young people (Bonafè et al., 2001). 
In a following study, we observed that this locus, rich 
in Alu sequences, contains a gene called YTHDF2 
that shows an increase in homozygosity in 
centenarians (Cardelli et al., 2006). In this study we 
genotyped 412 participants of different ages, 
including 137 centenarians, and we confirmed the 
increased homozygosity in centenarians at this 
locus, and observed a concomitantly increased 
frequency of the most frequent allele and the 
corresponding homozygous genotype. Remarkably, 
the same genotype was associated with increased 
YTHDF2 messenger RNA levels in immortalized 
lymphocytes. Thus, these data suggest a possible 
role of this locus in human longevity, and more 
interesting, they suggest the counterintuitive 
concept that increased homozygosity can contribute 
to human longevity. These results has been 
obtained thanks to the study of a genetically 
heterogeneous population, as humans are. In 
animal models, different strains are used, but the 
animals of each strain are rather homogeneous 
from a genetic point of view, thus making this 
discovery almost impossible in such models. When 
these results will undergo replication in animal 
models, genetically heterogeneous animals must be 
used. 
 
The role of the environment 1: the antigenic load 
 
An important environmental factor impinging 
upon longevity is the antigenic load, i.e. the number 
and intensity of antigenic stimuli to which everybody 
is exposed during lifetime (De Martinis et al., 2005). 
Besides the life-threatening risks of the exposure to 
highly pathogenic microorganisms, it is becoming 
  114evident that also the mild chronic exposure to 
antigenic stimuli (for example to viruses such as 
Cytomegalovirus, CMV) for a period of time largely 
unpredicted by evolution profoundly affects the 
possibility to attain longevity (Pawelec et al., 2006; 
Vescovini  et al., 2007). This life-long exposure to 
antigenic stimuli is one of the main causes of 
modifications occurring with age of the immune 
system, leading to the phenomenon known as 
immunosenescence and to an increase in 
inflammatory reactions that favours the onset of 
many age-associated diseases which do share an 
inflammatory pathogenic background, such as type 
II diabetes, cardiovascular diseases, neurodegenerative 
diseases and many types of cancer. This age-
related increase in inflammatory markers has been 
termed “inflammaging” by our group (Franceschi et 
al., 2000). The effect of such (acute or chronic) 
antigenic exposure is forcedly skipped out in most 
experimental models, where animals live in a 
pathogen-free environment. In particular, the role of 
chronic antigenic burden on longevity is extremely 
difficult to assess in animals living in a clean or even 
sterile environment. Furthermore, the immune 
responses are clearly very important in order to 
attain longevity, and not only the immune system of 
a mammal is much more complicate than that of an 
invertebrate, but also the characteristics of 
immunosenescence, i.e. the age-related 
modifications of the immune responses, can be 
strikingly different among species (Pawelec et al., 
2002). Such a confounding factor can overcome the 
effect of the gene of interest, thus leading the 
researcher to the conclusion that such a gene does 
not play a role in longevity. 
 
The role of the environment 2: the dietary 
restriction 
 
As mentioned at the beginning of this review, a 
striking difference between men and animal models 
regards metabolic regulatory processes. To date, 
the so called directionality theory distinguishes 
between species according to the ecological 
constraints they have to face within their ecological 
niche (Braeckman et al., 2006). According to this 
theory, two groups of species are recognized: 
equilibrium species and opportunistic species. The 
first group is composed mainly by large mammals, 
like humans, that spent the most part of their 
evolutionary history in a stationary growth phase, 
with a limited but roughly constant amount of 
resources. The latter group includes many small 
mammals like rodents, insects and worms like C. 
elegans. These species are subject to fluctuations in 
size because of irregular availability of resources 
(periods of abundance and scarcity). It is very likely 
that species belonging to the two groups, despite 
the fact that they can share genes or even entire 
metabolic pathways, may have a different behaviour 
in terms of survival in face of environmental 
challenges. For example, the best known treatment 
that extends life span in animal models (mainly 
opportunistic species, according to the directionality 
theory) is dietary restriction (DR), i.e. the reduction 
in food intake. Studies on C. elegans have showed 
that DR increases life span of such animals (Klass, 
1977; Lakowski and Hekimi, 1998; Houthoofd et al., 
2002). The same has been demonstrated for other 
“opportunistic” species that are classical animal 
experimental models, such as Drosophila and mice, 
but contrasting results have been reported on long 
living mammals and humans (Kayo et al., 2001; 
Roth  et al., 2004; Everitt and Le Couteur, 2007). 
Many data suggest that DR acts as a low intensity 
stressor and increases metabolic stability (Masoro 
1998, Butov et al., 2001). Equilibrium species, like 
humans, already have a strong metabolic stability, 
and thus DR would have a relatively small effect on 
such species (Braekman et al., 2006; Demetrius, 
2006). From survival studies on overweight and 
obese people, it is estimated that long-term DR 
could add 3 to 13 years to human life expectancy 
(Holloszy and Fontana, 2007), quite far from the 
dramatic effects observed in worms and rodents, 
and in any case much lower than the effects of 
improved life-style conditions. 
One of the effects of DR is the reduction of the 
insulin/IGF-1 signalling pathway (Clancy et al., 
2002), and, as mentioned, this pathway appears to 
be conserved throughout evolution from yeast to 
mammals. Genetic studies on humans have 
indicated that some polymorphisms of genes 
involved in insulin/IGF-1 pathway (IGF-1R, PI3KCB) 
are associated with longevity (Bonafè et al., 2003). 
These polymorphisms are correlated to low levels of 
IGF-1, and this finding fits with the data obtained in 
experimental models, confirming that lower activity 
of the insulin/IGF-1 pathway is a major determinant 
of longevity and that genes involved in such a 
pathway can be considered longevity genes. It is to 
note however that these and other genes, such as 
mTOR and p66
Shc, increase longevity when they are 
(at least partially) turned off, and their ablation often 
produces dwarf animals with a series of defects 
such as obesity and decreased fertility (Longo and 
Finch, 2003). Moreover, it has been reported that 
high levels of IGF-1 and low levels of pro-
inflammatory cytokines such as IL-6 are beneficial 
for muscle mass maintenance and are associated 
with decreased risk of mortality in old people 
(Barbieri et al., 2003). Thus, there is a clear trade off 
between early life fitness and longevity, and every 
species is the result of a million-years evolution that 
tuned between these two contrasting goals, 
reaching a peculiar equilibrium for any species. 
Hence, comparison between species in which this 
trade-off has led to a different equilibrium is risky. 
However, a series of possible pharmacological 
treatments have been envisaged to mimic the pro-
longevity effects of IGF-1 deficiency escaping in the 
same time the detrimental side-effects (obesity, 
dwarfism, infertility, sarcopenia) of this deficiency 
(Longo and Finch, 2003). 
 
Conservation and evolvability 
 
Recent conceptualizations stressed the 
importance of robustness as one of the fundamental 
properties of living organisms, from cellular (Stelling, 
2004) to organismal level (Kitano and Oda, 2006; 
Kitano, 2007), a characteristic acquired during 
evolution which allow them to be error-tolerant and 
to easily respond to external perturbations (Jeong et 
  115al., 2000). Metabolic stability appears to be 
genetically determined and respond to the requisites 
of robustness. On the basis of available data 
obtained from different organisms, especially yeast 
and Invertebrates, a “bow-tie”  organizational 
architecture is likely to be a common feature of 
highly organized, robust systems (Csete and Doyle, 
2002, 2004), which enables them to accommodate 
perturbations and fluctuations on many temporal 
and spatial scales. A bow-tie model is present when 
many inputs converge on, and are integrated by, few 
elements, and many different outputs come out as 
the product of the integration. The elements 
composing the core (“knot”) of the bow-tie in a 
biological system are “hub proteins” and the genes 
that encode them are likely to be in many cases 
robustness genes. Such a structure has also an 
inner fragility, because few enzymes responsible for 
robustness can be easily hijacked by pathogenic 
microorganisms or used to amplify pathological 
processes (Csete and Doyle, 2002; Kitano and Oda, 
2006; Kitano, 2007). Much of the core of a bow-tie is 
often conserved throughout evolution, but this 
conservation does not prevent, but rather facilitates 
the variability of the possible outputs. Thus, a bow-
tie structure allows both robustness and evolvability 
(Gerhart and Kirschner, 1997; Caporale, 2003). 
Longevity could be intended as a consequence of 
the robustness of the animal system. Indeed, it is 
conceivable that the outputs of a bow-tie structure 
include elements that ultimately control the life-span 
of the animal. If these elements can vary, as a feature 
of the bow-tie evolution, this variation may explain, 
at least in part, why knot genes, yet conserved, not 
always result to be involved in longevity on 
evolutionarily distant animals according to classical 
association or functional studies, thus casting some 
doubts on their role as real “longevity genes”.  
 
Conclusions 
 
Homo sapiens is one of the most long-living 
species among animals, but his longevity has had a 
dramatic increase in recent times, at least in western 
Countries, due to profound modifications in lifestyle. 
Thus, human longevity has two major components, 
whose effects are very difficult to distinguish, genetics 
and culture. This raises an insurmountable obstacle, 
since no animal species depends on culture as 
humans do. Thereafter, results obtained on animals 
studies not only must be always confirmed on 
humans, but they are also not completely satisfactory 
for a series of reasons: these studies do not consider 
neither the genetic and epigenetic differences existing 
between men and animal species, even those much 
close to humans, nor the influence of culture on the 
duration of the life after the age of reproduction, i.e. 
after the period influenced by natural selection. As an 
example of specific genetic differences between man 
and animals, it can be mentioned the case of TP53 
gene. This gene is crucial for a series of biological 
processes such as apoptosis, cell senescence, DNA 
repair, and energy metabolism, and is considered a 
longevity gene in both animals and humans 
(Donehower, 2005). In humans TP53 gene harbours a 
common functional polymorphism at codon 72 which 
alters the protein' functions (Thomas et al., 1999; 
Dumont  et al., 2003; Bonafè et al., 2004). This 
polymorphism has been and still is under investigation 
for its possible involvement in longevity (Bonafè et al., 
2002; Van Heemst et al., 2005), and such effects, if 
any, can be detected only in humans, because this 
polymorphism does not exist in Chimpanzee, while in 
mice it seems to have no effects (Phang and 
Sabapathy, 2007). Moreover, our data indicate that the 
effects of such a polymorphism become evident as 
the age of the studied subjects increases (Bonafè et 
al., 2004; Salvioli et al., 2005) thus suggesting that the 
role of such a gene does change with age. This could 
be a case of antagonistic pleiotropy, that is, a gene 
that has a positive effect for fitness at young age could 
turn to be detrimental later on, in a period of time not 
selected for reproductive fitness, or vice versa. The 
genetics of human longevity has thus been proposed 
to be described as a post-reproductive one (De 
Benedictis and Franceschi, 2006). It is at present 
unknown whether also laboratory animals have a 
post-reproductive genetics, and which similarities it 
has with the human one. In conclusion, animal models 
remain an irreplaceable tool to shed light into the 
genetics of aging and longevity, but the transferability 
of the results to humans is always an issue.  
As discussed all along this review, longevity 
genes are classically identified by their association 
with an extended life-span, but for a series of reasons 
this strategy is not always successful, and results can 
not always be reproduced in different experimental 
models. Here we propose the idea that longevity 
genes could be identified by an alternative strategy. As 
mentioned, conservation and evolvability are inherent 
features of the bow-tie structures, that determine 
robustness. If robustness is important for longevity, it 
can be hypothesised that longevity genes should 
participate with a core position to a bow-tie metabolic 
structure. We propose that a new way to identify 
putative genetic determinants of longevity could be the 
conservation of their products in bow-tie structures all 
along evolution, rather than for their association with 
prolonged life-span. In this perspective, studies of 
comparative biology associated with a systems 
biology approach could be useful tools to get some 
insights also into the genetics of human longevity. 
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